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ABSTRACT
Through independent but unconfirmed physiological
mechanisms, ibuprofen (rB) and vitamin E (E) are each
proposed to potentially attenuate delayed onset muscurar
soreness (DoMs) that often accompanies novel eccentric
exercise. The purpose of this study was to determine
whether or not the use of rB or E reduces the rating of
soreness (RS) associated with DoMs or affects the decline
in muscular performance that usualry accompanies DoMS.
A secondary purpose was to determine the accuracy of each
grouprs perception of performance (pp) folrowing the
onset of DOMS. rt may be hypothesized that if rB or E
alter perception during DoMS, then susceptibirity to
muscre injury upon subseguent performance courd also be
impacted. Twenty-nine college-aged femares were randomly
assigned in double-brind fashion to either an E (8oo
IU/d)′   IB  (■200  mg/d)′or placebo (p) group.
Administration of E or p began L4 days prior to and
continued throughout the 5-day testing period, while rB
began 2 days prior to and continued throughout the
testing period. Baserine measurements consisted of
maximar isometric, eccentric, and concentric contractions
of the guadriceps and hamstrings on a Biodex isokinetic
dynamometer. rmmediately after baserine testing,
subjects performed a series of intense sguats to induce
muscular soreness in the upper regs. RS and pp were
assessed daily with Likert-type scales. The four
subseguent testing days were used for comparison to the
baserine, and to examine differences between condj_tions.
Multivariate mixed moders were used to compare the three
groups on selected rise time (RT), peak torgue (pT), and
time to fatigue (TTF) measurements across the five
testing days. Rs and pp measures were analyzed with a
nixed model ANovA. Analysis of RT was not significant
indicating that arI groups achieved pr in a similar
fashion on each day. The group x day interaction for pr
was significant (p<.05), however, the analyses of simple
group effects were not significant for each day. The
time main effect was significant between Days 2 and 5,
indicating a drop in muscular perfornance forrowing the
occurrance of DoMS. Analysis of TTF revealed both a
significant interaction and time main effect (p<.05).
simpre effects for groups at days showed significant
differences between the groups only at Day l, however,
follow up contrasts showed no significant differences
between the groups at Day 1. Bonferroni contrasts for
time main effect also showed no significant differences
betweenmean scores on Days 2 and 3, 2 and,4, or 2 and 5.
A mixed model ANovA for pp showed a significant time main
effect (p<-05), and folrow-up contrasts showed
'significant differences between mean scores on Days 2 and
4, and Days 2 and 5 (p<.05). The IB grouprs pp tended to
be consistently lower than E or p, however, this trend
did not reach statistical significance (p:.Oge).
Analysis of RS showed no group differences, but a time
main effect revealed that soreness peaked by 4g h
postexercise and began to recede thereafter. The use of
rB or E does not appear to enhance the perception of
performance nor does it appear to have an ergogenic
effect during DOMS.
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Chapter 1
TNTRODUCTION
Derayed onset muscre soreness (DoMs) is defined as
a du1l, aching pain in the skeletal muscles that
develops 24 to 48 hours following unaccustomed
activity, and can last from 5 to 7 days (Armstrong,
l-984). The mechanisms responsible for the perception
of pain rerated to the soreness have not been clearly
identified, although the concept, etiology, and,
mechanisms were first introduced nearly a century ago
(Hough, L9O2').
Almost everyone has experienced muscle soreness at
some time, especially after the first or second day of
a new exercise program. Through independent though
unconfirmed physiological mechanisms, ibuprofen and
vitamin E are each proposed to potentialry dininish
DOMS that often accompanies novel eccentric exercise.
The questions remain, are ibuprofen and vitamin E
effective in reducing DoMS? And, wilr these substances
reduce the perception of pain and herp to maintai-n
normal muscurar perforrnance in a person experiencing
DOMS?
2This study was designed to investigate if a
nonsteroidal anti-inflammatory drug (NSAID), such as
ibuprofen, would decrease pain associated with DOMS or
reverse the decline in muscular performance that
usually accornpanies DOMS. In addition, the recent
suggestion that vitamin E may serve as an antioxidant
protecting against free radical induced damage to the
muscle ceII membrane, and possibly against soreness,
was also investigated (Jenkins, L983). A secondary
purpose of the study was to determine the ibuprofen,
vitamin E, and placebo groupsr perception of
performance ability following the onset of DOMS.
Scope of the Problem
This study was conducted to investigate whether
the use of ibuprofen (IB) or vitamin E (E) has a
positive effect on reducing muscle soreness and/or the
associated decline in muscular performance that occurs
with unaccustomed resistive exercises. Twenty-nine
femare undergraduates at rthaca colrege vorunteered to
serve as subjects. They were divided into 3 groups, dr1
IB, an E, and a placebo (P) group. The E and p groups
began ingestion of the designated dosage 2 weeks prior
to testing, while the IB group began 2 days before
―
―
?
testing. A11 three groups continued ingestion
throughout the five testing days. On the first day of
testing, all groups performed a series of maximal
resistive exercises on the Biodex (to gather baseline
data), followed by a routine of near maximal squat
exercises designed to induce DOMS. For the following 4
days, muscular performance was determined by repeating
the maximar resistive exercises on the Biodex. Ratings
of soreness and perception of performance scares were
given prior to initial testing, and before muscular
performance testing.on each subseguent day.
Statement of the problem
This study was conducted to determine whether use
of rB or E prior to and folrowing unaccustomed exercise
reduced the perception of pain or the decline in
muscular perfonnance related to DOMS. It was also
determined whether a rerationship existed between
measures of perceived performance and perceived
sensations of soreness.
Hvpotheses
The nuIl hypotheses of the study were as follows:
1. Ho: Muscurar performances on the Biodex do not
differ significantly among E, IB, and p subjects
4following unaccustomed sguat exercises.
2. Ho: Perception of soreness and performance
scales do not differ significantly among E, IB, and p
subjects in response to unaccustomed sguat exercises.
Assumptions of Study
The following were assumptions of the study:
L. The subjects used maximum effort during the
maximal resistive exercises.
2. The protocol used in this study was*sufficient
to induce muscle soreness in the target muscle groups.
3. The placebo group was representative of both
the E and IB groups.
4. The subjects used IB, E, or p as prescribed
throughout the study.
Definition of Terrns
The folrowing terms are defined for the purpose of
this study:
L. Isokinetic: The speed of 1imb rotation is
performed at a constant value throughout the range of
motion during the exercise (Kreighbaum & Barthers,
r.e8s).
2. One repetition maximum (1 RM): the weight of
the load that can be lifted one time onIy.
3. Maximal resistive exercise: All out effort
during contraction of a muscle.
4. Untrained subjects: Women who have not
regularly strength trained their lower body for 3
months prior to the study.
Delimitations of Study
The delimitations of the study were as fotlows:
L. Twenty-nine female undergraduates from Ithaca
College were recruited as subjects.
2. Only non-smoking, untrained subjects were
selected for participation in the study.
3. Following a brief warm-up, five sets of LO
repetition squats at 80? of l_ RM were the only
exercises used to induce soreness.
4. The perception of performance and soreness
scares were the onry subjective measures used in the
study.
5. Muscular performances on the Biodex were the
only objective measures used in the study.
6Limitati-ons of Studv
The limitations of the study were as follows:
l-. The subjects used may not be representative of
the total female undergraduate population.
2. Results may only be generalized to guadricep
and hamstring soreness induced by universal sguat
exercises at 80? of l- RM for five sets of LO
repetitions.
3. subjective measures may only be generalizable
to the perception of performance and soreness scales.
4. Objective measures may only be generalizable
to muscular performances on the Biodex.
Chapter 2
REVIEW OF LITERATTIRE
DOMS is a condition recognized by most people.
Because of the multitude of people it afflicts,
explanations for this phenomenon, whether factually
based or not, are freguently proposed. fn turn, one
would think that research in this area would be
reratively concrete with few remaining guestions. on
the contrary, little is known about the basic
etiorogies and mechanisms invorved in DoMS (Armstrong,
l-984). The present study examines the effects of
vitamin E and ibuprofen on muscurar performance in the
presence of DoMS. This review of riterature addresses
the following topics: (a) model of DOMS, (b) pain
mechanisms, (c) consequences of DOMS, and. (d)
treatments.
Mode1 of DOMS
There is generar agreement among researchers that
the degree of DOMS one experiences is rerated to both
the intensity of muscular contractions and duration of
the activity. rntensity seems to be the more critical
of the two factors. However, there is disagreement
about which of the many factors associated with
increased force production is specificarly responsible
for DoMS (Armstrong, r-984). Mechanisms invorved in
7
DOMS that have been proposed by Armstrong are:
structural damage, metabolic waste accumulation,
temperature, and altered neural control. Armstrong
devised a model that describes the sequence of DOMS
events based on available data: (a) high tensions, (b)
ceII membrane disruption, and (c) macrophage activity.
Hiqh Tensions
Eccentric exercises, as compared to concentric and
isometric, are known to produce greater tension per
fiber and as a result, greater muscle soreness. To
produce a given muscle force, fewer motor units for
eccentric exercises are activated, and thus force is
distributed over a smaller cross-sectional (recruited)
area of the muscre. This action causes a disruption
of structural proteins in muscre fibers and connective
tissue between active cross-bridges and the bony
attachments (Armstrong, 1984). In support of this
theory, Tiidus and fanuzzo (L993) found that high
intensity, short duration eccentric exercises produced
DOMS and changes in creatine kinase (CK), a serum
enzyme marker for tissue damage. The different
intensities and durations that were tested indicated
that a relationship exists between work performed, 24-
hour post-exercise serum cK activity, and magni_tude of
DOMS in untrained individuals.
A study by Friden, Sjostrom, and Ekblom (L981,
L983) showed myofibrillar disturbances following
eccentric exercises in nainly fast-contracting, type rr
fibers immediatery pos€bxercise and up to 3 days later.
Friden et aI. (1983) speculated that the type IIb
fibers with narrow z-bands may also have a significant
metabolic demand praced on them, which may further
exacerbate the risk of darnage to the inherently weak Z-
disks. In opposition to this finding, Armstrotrg,
warren, and warren (L991) found predominantly srow-
twitch fibers were most affected in eccentric downhirL
running by rats, arthough no urtrastructurar fiber
typing was performed in the study.
A study comparing the effects of eccentric,
concentric, and isometric exercises on ratings of
soreness (RS) and serum cK activity showed both
eccentric and isometric exercises increased the
perceived soreness, with eccentric producing greater
perceived soreness. Both types of exercise also caused
a significant increase in absolute and rerative cK but
there was not a significant difference between the two
exercises (C1arkson, Byrnes, McCormick, Turcotte, &
White, l-985). In their study on rats, AppeII, Soares,
and Duarte (3-992) considered both eccentric and
concentric prolonged exercises to compare the metabolic
and mechanicar origins of muscle damage. As expected,
the concentric proronged exercise group (1 h of level
running) showed changes in the striation pattern,
predominantly in fibers which were also glycogen
depleted. In addition, dr increase in the
concentration of lysosomal enzymes was found,
suggesting a primariry metaboric origin of contractile
materiar breakdown. The eccentric downhilr running
group exhibited higher incidence of damaged fibers and
at the same time, an absence of glycogen-depleted
fibers, lending more support to the mechanical origin
of damage.
CeIl Membrane Disruption
Structural damage to the sarcolemna, or
disruptions in the permeabirity of the cerr membrane as
a resurt of high tension forces, is accompanied by an
infrux of carcium (ca++1 from the interstitiar tissue.
This abnormar influx of ca++ inhibits cerrurar
respiration, which lowers the ceIIrs ability to produce
Ll_
ATP and therefore, slows oxidative phosphorylation.
This event can activate certain calcium-dependent
enzymes that degrade z-discs, troponin, and tropomyosin
filaments (Armstrong, L984) .
rn agreement with Armstrongts model of DoMS, Friden
et ar- (l-983) found simirar conclusions in their own
investigation to further varidate the rrmechanical
disruption theoryr'. The authors hypothesized that in
addition to mechanical overload (e.g., eccentric
exercise), excessive ca++, rysosomal enzymes produced
in damaged fibers, and alfa-actinin or Z-line
proteinase (activated by Ca++) could also be
responsible for Z-band disruption
Byrd (]-992) hypothesized that the involvement and
alterations in the sarcoplasmic reticulum (sR) might be
a rink to exercise-induced muscle damage. possibre
causes of altered sR function forrowing strenuous
exercise incrude a decrease in muscre pHr dD increase
in muscre temperature, altered metaborismr drr increase
in oxygen free radicalsr or fruid and ion shifts. Byrd
hypothesized that a combination of these effects may
occur since no one mechanism is present in arr types of
exercise. The sequence of events eventually reading to
L2
fiber necrosis (death) may be alterations in the SR
structure and function, followed by an increase in cerr
ca++ concentration, stimulation of muscle degradation
by calcium-sensitive proteases (acting on Z-Iines) and
carcium activated phospholipases (acting on proteins in
cell membranes) and finally, muscle damage.
Another study by OrReilly et aI. (L987)
investigated impairment of glycogen repletion folrowing
eccentric exercise. They attributed the delay in
glycogen repletion and nyofibrillar damage to
alterations in the sarcoremma based on the appearance
of large proteins such as CK, Iactate dehydrogenase,
and myoglobin in the interstitial space. Because
glucose transport into the cell may be the rate-
liniting step in grucose utilization in the resting
muscle (post-exercise), the effect of the altered
membrane permeability courd have resulted in ress
glucose available in the cerl for grycogen resynthesis
(O'Reilly et dI., L9B7).
Macrophage Activity
Following the progressive deterioration of the
sarcolemma in the postexercise period, comes the
accumulation of intracellurar components into the
L3
interstitial fluid. These substances attract monocytes
that convert to macrophages, and in turn, activate
histocytes in the injured area. Active phagocytosis,
cellu1ar necrosis, inflammatory edema (swelling), an
increase in local temperature, and accumulation of
analgesic agents (histamine, kinins, potassium), then
stimurate the nociceptors in the free nerve endings of
the muscle resulting in the sensation of DOMS
(Armstrong, L984).
In strong support of acute inflammation as the
underrying mechanism in DOMS, smith (L991) emphasized
the similarities between the sensation of soreness and
the acute inflammatory response. rn her brief review,
she noted that both events exhibit markers of pain,
swelling, and loss of function, heat and redness,
evidence of cerrular infirtrates (i.e., macrophages) at
24 h and 48 h after initial tissue disruption,
biochemical markers such as increased lysosomal
activity and increased circuration of proteins, and
signs of historogicar (tissue) hearing at approximately
72 hours. Although not arl tirne frames associated with
DoMs coincide with those described for acute
inframmation, the majority did. smith concruded that
t4
because the body responds to arl forms of acute tissue
injury by initiating the j-nflammatory response, there
is no need to believe a separate response has evolved
to combat an injury brought about by unaccustomed
eccentric exercise.
Pain Mechanisms
The sensation of pain in skeletal muscle is
transmitted to the conscious lever by myelinated
III and unmyelinated group IV afferent fibers
group
(Armstrong, r-984 i Byrnes & clarkson, 1986) . Both group
rrr and group rv sensory neurons terminate in free
nerve endings around the muscle fibers and are
distributed primarily in the regions of capilraries,
arteriores, and at the musculotendinous junctions
(Byrnes & Clarkson, t_986) . The group IV fibers,
classified as nociceptors and metaboceptors, are two
times greater in number than the group rrr fibers and
are known to carry duIt, diffuse pain. rt is rikery
that the sensation of DoMs is carried prinarily by
group IV neurons.
The nociceptors respond to noxious stirnuli while
the metaboceptors respond to mechanicar and/or chemical
changes produced by contracting muscre. Acutely
15
damaged cells cause the pain sensation by producing
noxious stimuli. Swellirg, inflammatory products
associated with elevated locar temperatures, rerease of
endogenous chemicars r ot a combination of the three
could be considered noxious agents. The chemical
substances are shown to activate nociceptors and appear
to have their own separate receptor sites on the free
nerve endings (Armstrong, L9g4).
According to Berne and Levy (1993), bradykinin
(associated with the sensation of durr pain) and other
short-chain pollpeptides are presumed to be cleaved by
enzymes released by necrotic cerls circulating in the
blood. The time deray between the occurrance of injury
and sensation of pain, mdy be due to the time it takes
for cerl-s to die and noxious agents to accumuLate.
Pain is arso thought to be transmitted via central
nervous system pathways. The spinar cord, brain stem
and thalamus, and the sensory cortex arr contain
various receptors and pain rnodulating abilities which
may explain the large intersubject variabirity found in
the perception of soreness postexercise (Byrnes &
Clarkson, l-986; Clarkson et aI., L9g5).
The biochemical mechanisms underlying skeletar
16
muscle soreness and damage with unaccustomed exercise
remain unclear. However, evidence is accumulating that
oxygen free radicals play an important part as
mediators of skeretar muscre damage and inflammation
(Sjodin, Westing & Apple, J-990). During exhaustive
exercise, the musclers oxygen uptake can increase up to
more than l-00 times normal (Amelink, van der Wa1,
wokke, van Asbeck & Bar, r-99r.). At the same time, the
rate of ATP utilization exceeds the rate of ATp
production and creates a metabolic stress. The
metabolic stress within the cerl resurts in a marked
increase in the production of oxygen free radicals
(sjodin et aI., r-990). These free radicals attack
polyunsaturated fatty acids and initiate lipid
peroxidation which in turn, damages membranes and may
thus play a part in enzlmre rerease and (focal) muscre
necrosis (Amelink et aI., L991).
vitamin E, or alpha-tocopherol is a fat-solubIe
compound that exists in minute guantities in the cerl
membrane and helps to stabil ize the cerl by interaction
with poryunsaturated phospholipids. Vitamin E also
exhibits antioxidant properties as it serves as a
chain-breaker and helps to prevent the propogation of
t7
lipid peroxidation (Jenkins, l-988) .
Performance Consequences
fn 1902, Hough became the first to note that the
force of a maximal contraction is reduced in sore
muscles. He suggested that the decrease in performance
resurted both from reduced voruntary effort due to
perceived muscle soreness, and to an inherently rowered
capacity of the muscre to produce force (Hough, Lgo2).
Two subseguent studies support Houghrs
obserrrations that performance is reduced in sore
muscres. Both experiments, using direct erectrical
stimuration, found the abirity of muscres to produce
force was lowered (Davies & white, L9g1; Newham, Mi11s,
Quigley, & Edwards, L9g3). However, Newham and
coworkers arso found that muscre force returned to
normal by 24 h postexercise which preceded the tirne
when sensations of soreness reached maximum intensity.
In agreement with this finding, Friden et aI.
(l-983) found discrepencies in the amount of time
between the development of soreness and the decreases
in strength. Resurts indicated that strength losses
did not occur at peak soreness, therefore it courd not
be concruded that pain arone affected strength.
L8
In another study, the effects of eccentric
exercise on motor performance in young and older women
!.rere examined. One point that was noted was a
reduction in isometric force which occurred in both
older and younger women. Secondly, the rate of
recovery to baserine strength was significantry slower
in older than younger women, which was expected.
However, the researchers attributed the slow strength
recovery not to pain associated with soreness, but
possibly to caution against injury exhibited by the
older subjects exerting maximal force (Dedrick &
Clarkson, L989).
Similar1y, Clarkson and Tremblay (t-988) also ruled
out apprehension and pain torerance as causes for the
reduced ability by college-age women to produce force.
rnstead, they concluded that at rower frequencies of
stimulation, the reduced abirity to generate force was
due to a damaged sarcoplasmic reticulum shown by an
influx of Ca++ and delayed appearance of CK in the
bIood.
In yet another study, Friden et aI. (L983)
suggested from their findings that muscre weakness
during isometric and dynarnic contractions forrowing
L9
eccentric exercise might rery on the amount of motor
unit activity invorved in force generation, which in
turn, might depend on damage to contractile fibers. rn
particular, they found that the type II fibers were
more extensively damaged at higher angular velocities
than type l, which explained the slower recovery rate
for type rr at the faster speeds. They also pointed
out the fact that 3 days after eccentric exercise,
subjects experienced considerabre pain on movement
(especiarly fast movements) which might have limited
the maximar contraction strength they could reach
voluntarily.
Treatments
Early experiments by Hough suggested that
performance of the specific motor task that induced
DoMs would resurt in arleviation of the discomfort fert
afterward and possibly have a prophyractic effect
(Hough, L9o2). subseguent research has supported this
hypothesis on many occasions, though some differ in
their conclusions on the duration of the rprotective,r
effect
similar resurts were found in three investigations
that included a single bout of exercise. During
20
subseguent activity, one study found a decrease in
serum protein responses (an indirect assessment of
muscle danage) and an increase in DOMS following
eccentric contractions. These effects lasted up to 6
weeks (Byrnes et aI., l-985). Two other studies found
similar results from isometric contractions with
prophylactic effects rasting onry 3 weeks (Triffletti,
Clarkson, & Byrnes, l_985; Trif fletti, Litchf ie1d,
clarkson, & Byrnes, r-9gg). Due to the difference in
resurts, Triffletti et, ar. (1985, t-988) suggested that
future studies first examine the time course of the
rapid adaptation effect for the specific exercise model
being used.
Following a comparison of uphill, Ievel, and.
downhilr training methods, Schwane and Armstrong (1983)
also supported Houghrs hypothesis. They found that a
singre bout of eccentric downhirr running herped in
decreasing the appearance of plasma enzymes (indicating
muscre fiber injury) in subseguent bouts of proronged
downhill running. Clarkson and Tremblay (1988)
continued investigating the repeated bout effect and
rapid adaptation to eccentri-c exercise in humans.
Their protocol included eight female subjects
2t
performing 7O maximal (max) eccentric forearm
contractions with one arm, and 24 max followed by 70
max forearm contractions (2 weeks later) with the other
arm. The results suggested that the minor intensity
bout of eccentric exercise (24 max) was sufficient to
produce an adaptation such that the strength of the
surrounding connective tissue protected the membrane
against further damage and possibly a loss of
sarcolemmal integrity.
Arthough evidence of its worthiness to treat DOMS
is incomplete, the recreational use of anti-
inflammatory drugs is increasing at a rapid pace.
Janssen, Kuipers, Verstappen, and CostiII (L9g3)
conducted a study on the effects of flurbiprofen (a
prostagrandine aritagonist) on muscle soreness and serum
cK changes. They concruded that the drug had no effect
on soreness or enzyme release. One aspect to consider
was the design of their study and the fact that using
repeated bouts of exercise may have masked the actuar
effect of the drug (Byrnes & Clarkson, l_986).
rn another study, Muckle (L974) compared ibuprofen
and aspirin in terms of their anargesic effects on soft
tissue injuries and effectiveness. using a doubre-
22
blind tria1, the author suggested that ibuprofen
significantry reduced the period of pain, the time to
return to soccer training, and the time to become match
fit as compared to aspirin. The only stipuration the
researchers pointed out was that the drug wourd have to
be administered within a short period after injury, So
as to coincide with the occurrance of rocal bi_ochemical
changes.
Conversely, in a double-bIind crossover study,
anti-inflammatory drug Dicrofenac was found to have
influence on exercise-induced muscle damage (serum
enzyme changes) nor did it reduce overall soreness.
However, it did rerieve some specific individual
soreness during the first period of the study. Tl"
reasons for these findings hrere unclear to the
researchers as they raised the possibility that an
interaction occurred between the action of the drug and
the repeated bout effect (Donnerry, Mccormick, Maughan,
whiting, & clarkson, r-988). A review by Evans (LgB7)
suggested that since prostaglandins increased muscle
protein synthesis, inhibiting their production would
prevent or possibly srow muscle repair, making the
muscre more susceptibre to further damage. But, the
??? ???
?
???
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results showed otherwise and the damage may have
actually protected against further soreness.
Recently, the possibility that vitamin E plays a
role in the maintenance of cel1 continuity during
exercise has been studied. rn Lgg4, packer conducted
an experiment manipulating dietary vitarnin E and
exercise to look at the rerationship between metabolic
rate and tissue oxidative damage. one group of rats
was endurance trained for g weeks on a treadmirr and
another group remained sedentary with a diet totalry
deficient in vitamin E. Results showed the revel of
damage vras greater in vitamin E deficient animars
before exercise. The other important findings were:
ATP production was markedry decreased in skeretar
muscre mitochondria of exercised rats and even more so
in vitamin E deficient rats; prolonged exhaustive
exercise decreased latency of rysosomal enzymes which
might contribute to tissue damage; rate of lipid
peroxidation increased, and the amount of stable free
radicals increased.
Quintanilha (L994) conducted a similar experiment
controlring dietary vitamin E among sedentary and
endurance trained rats. During the 9 weeks, two groups
out of four were fed 4O IU d1-alpha-tocopherol per
kg/body weight. The other two groups were fed L5 IU
per kg/body weight for the first 5 weeks, then no dI-
alpha-tocopherol for the remaining 4 weeks. Ten
animals from each of the two dietary groups were
endurance trained and the folrowing results were the
found: red cell hemolysis increased in only the vitamin
E deficient group (1s ru to no vitamin E) and between
trained and sedentary groups, hemolysis occurred L week
later in the endurance trained group. euintanirha
concruded there hras a need for increased vitamin E
during endurance training and arso a possibility that
training produces a protective effect against red cerl
hemolysis despite vitamin E deficiency.
Another study utilizing rats, focused on the
possible effects that increased extracerlular vitamin E
would have on the response of skeletar muscles to
damage induced by erevated intracerrurar ca++. The
soreus muscres of the rats were analyzed after the
addition of ca2+ ionophore (20 um) at 30 nin intervars.
Resurts showed an expected release of intracerlurar cK
and, following the addition of 230 um of alpha-
tocopherol, a total inhibition of the rise in cK effrux
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(as well as a maintainence of low level release)
throughout the 3 h period of the study (phoenix,
Edwards & Jackson, L989). These results may be helpful
for the case of vitamin E supplementation and its
rrprotective effectrr .
Summarv
DOMS stil1 remains a controversial issue. Ever
since L9O2 when Hough first cleared the path in the
recognition of this phenomenon, the etiologies and
mechanisms, performances consequences and most
beneficial treatments for it are sti1l being
questioned. Because of the nature of DoMS and the many
variables involved, there may never be one right
sorution to the probrem. Future study shourd focus not
only on how muscre soreness/damage occurs, but arso how
it can be prevented or arreviated. The use of vitamin
supplements and anti-inframmatory agents is stirr being
arguedr 
€rs many individuars may be spending needlessly
on such substances. Therefore, continuous research
must be emphasized to better understand aII the
mechanisms and hopefurry find reliabre treatments for
DOMS.
Chapter 3
METHODS AND PROCEDURES
This study was designed to investigate if IB
and/or E would decrease the sensation of pain and
thereby maintain muscular performance associated with
the presence of DOMS. A secondary purpose was to
determine the relationship between perceived
performance and the perception of soreness forlowing
the onset of DOMS. This chapter is divided into the
following sections: (a) selection of subjects, (b)
testing procedures and instrumentation, and (c)
treatment of data.
Selection of Subjects
Data collection for this study was conducted
during the spring of Lgg2. subjects were recruited by
announcements to classes in the school 0f Health
science and Human performance at rthaca college and
through personal communication. Twenty-nine femares
ranging in age from 18 to 2g years volunteered, and
were accepted for participation. prior to beginning
the study, each subject firred out a medicar history
guestionnaire (Appendix A), and read and signed an
26
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informed consent form describing the experimental
procedures (Appendix B). If a candidate had no
contraindications for exercise testing as outl-ined by
the American College of Sports Medicine (l-99L) and had
not strength trained her lower body for 3 months prior
to testing, she was accepted for participation.
Thirty-five subjects began the study, however 6 dropped
out. Two subjects became i11, and four subjects did
not comply with all testing procedures during the
study.
Testing Procedures and fnstrumentation
A11 subjects completed five sessions of data
collection. The first was a baseline measure of
isometric, eccentric, and concentric maximal resistive
exercises. The next four sessions were used to forrow-
up on these measures after muscle soreness was induced.
Explanations and directions were given prior to each
test in addition to a warm-up/practice period. The
data colrection sessions are subseguentry described in
greater detail-.
Through a random, double-b1ind procedure, each
subject was assigned to one of three groups. One group
took 800 fU of d-a1pha tocopherol (Henkel Corporation,
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#S Oval Softgel, LaGrange, IIl) (vitamin E) daily for 2
weeks prior to and throughout the 5 days of testing.
The second group took a placebo tablet twice a day, for
the first L2 days, and then i-2OO rngld of ibuprofen
(Fays Drugs, 2 x 200 mg each, Ithaca, Ny 3x/day) for
the next 7 days of the testing period. The third group
served as a contror and took two placebo tablets/day
(B.C Cowley Co., 5.0 grain, Shrewsbury, MA) for 2 weeks
prior to and throughout testing. To ensure
compliance, each subject was periodicarly asked whether
or not they were following their schedule of ingestion
and if there were any concerns regarding it.
Baseline Testing Session (Day 1)
Upon entering the 1ab, each subject completed a
24-hour health history (Appendix C) followed by a
pretesting overall soreness scale (Appendix D). The
24-hour hearth history questionnaire was completed each
day prior to testing to assess overall feeling, sleep
patterns, and activity done in the previous 24 h. The
subject was then seated on the Biodex with securely
fastened belts across the chest, Iap, over the dominant
Ieg, and around the lower shin. The proper height and
position of the chair r{ere found by lining up the
Iateral condyle of the femur to the center of the
attachment shaft, ds recommended by the manufacturer
(Biodex Corp. Shirley, NY, L98B). Once the subject was
in the correct position, biographical information (e.g.
name, i.d. number, sex, birth date, height, weight,
etc. ) was entered into the Biodex computer and saved.
Before the test triarsr Eln explanation of the test was
given followed by a warm-up period of l_5 submaximal
concentric (dynanic) contractions. Baseline strength
measurements were then determined by the performance of
maximal resistive exercise tests on the Biodex. The
sequence of tests were as follows: (a) isometric, (b)
eccentric, and (c) isokinetic.
Isometric Testincr (Dav 1)
An angle of +60 deg was used for all isometric
tests performed. Direction L was defined as a maximar
contraction of the guadriceps and was performed for a
duration of l-0 s with l- min of rest between each set
for a total of three sets. Direction 2 was defined as
a maximal contraction of the hamstrings, and was
performed for the same duration and total sets
following the performance of the Direction l_ tests.
Eccentric Testing (Dav 1)
Two minutes after the completion of the isometric
tests, a test of maximal eccentric contractions of the
upper leg was performed by each subject. In the
ttpassiverr mode, a speed of 60 deg/s was set for the
performance of three sets of eight contractions wittr 1
min of rest between each set. To perform eccentric
contractions of the quadriceps and harnstrings, the
subject contracted her muscles in opposition to the
robotic motion of the Biodex.
Isokinetic Testing (Day L)
Two minutes after the completion of the eccentric
tests, the isokinetic test was conducted. At a fixed
speed of L2O deg/s, the subject was told to perform
eight repetitions consisting of 1eg flexion and
extensions as hard and as fast as possible. A total of
two sets were performed separated by l- min of rest.
The sets were followed by a |ttime to fatigue'r (TTF)
test. The subject was given the same instructions as
previously stated, but was told to continue performing
repetitions until her peak torgue diminished to half of
maximum on three consecutive contractions as noted by
the tester. After a 2 min rest period, a fixed speed
of 60 deg/s was set for the
three sets of eight maximal
The entire testing sequence
4 days for comparison to the
fnducincr Soreness (Day 1)
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subject to perform another
leg flexion and extensions.
was repeated over the next
baseline measures.
Immediately after the baseline testing was
completed, each subject was escorted to the weight
room. The Universal sguat machine was the apparatus
used to induce soreness (Universal Gym Eguipment Co.,
Cedar Rapids, IA). Through trial and error, each
subjectrs l- RM was determined. subsequently, five sets
of Lo repetitions using 8oz of L RM were used in the
soreness induction protocol. Each set was separated by
15 to 20 seconds of rest. Following the last set, an
eccentric set of ten repetitions was performed at 8oz
of L RM. Two testers aided the subject by 1ifting the
weight, but then allowed the weight to be lowered
eccentrically by the subject. If a subject could not
successfully complete a squat or showed other signs of
extreme fatigue, the soreness protocol was terminated.
Following the soreness induction protocol, each subject
completed a post-test soreness scale based on
sensations in both the exercised (dorninant) Ieg and the
nonexercised leg (Appendix D).
Follow-up Testing (Days 2-5)
In the four days following the initial Biodex
measurements and soreness induction, testing was
performed and the results were compared to baseline
measurements and used to examine differences among
treatments. Upon arriving each day, the subjects
completed a 24-hour history, a soreness scale, and a
perception of performance scale prior to Biodex
performance. The perception of performance scale
(Appendix E) was a prediction by the subject of how
they thought they would perform compared to their
previous dayts performance.
Treatment of Data
Descriptive statistics were determined for the
following variables: Rise time (RT), peak torgue (pT),
and TTF. A multivariate mixed model analysis of
variance (Schutz & Gessaroli, 1,987 ) was used to
determine whether any differences existed in RT among
groups across the 5 days. The leve1 of significance
was set at .05. The three dependent variables used
were eccentric rise time at 60 deg/s (RTECCSO),
isokinetic rise time at 60 deg/s (RTISO6O), and
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isokinetic rise time at LzO deg/s (RTISOL2O). The
between-subjects variable, treatment group, consisted
of the E, fB, and P groups. The within subject
variable, day, included the repeated measures over the
5 days.
A multivariate mixed model analysis was also used
to determine whether any differences existed in pT
among groups across the 5 days. The three dependent
variabres used were isometric peak torgue for direction
2 (PTIDIR2), eccentric peak torque at 60 deg/s
(PTECC60), and isokinetic peak torque at l.,2O d.eg/s
(PTrsol-20) . The between-subjects variabre, treatment
group, consisted of the E, IB, and p groups. The
within subject variable, day, included the repeated
measures obtained over the 5 days.
Two mixed model analysis of variances were used to
determine whether any differences existed in perception
of Performance (PP) and RS. The between-subjects
variable for both analyses, treatment group, consisted
of the E, IB, and P groups. The within-subject
variable, day, included repeated measures obtained over
the 4 days for PP and 5 days for RS. The SPSS MANOVA
procedure was used to perform all of the analyses.
Chapter 4
ANALYSIS OF DATA
This study was conducted to determine whether or
not the use of rB or E reduces the perception of pain
associated urith DOMS and/or affects the decrine in
muscular performance that usually accompanies DoMS. rn
addition, each grouprs perception of their ability to
perform was assessed following the onset of DOMS.
statistical analyses of these data are described in
this chapter.
Description of Subjects
Twenty-nine college-aged females were recruited
for this study. Acceptance into the study hras gained
if the individuar met the folrowing criteria: (1) had
not done rower body strength training within the rast 3
months, (2) had no known allergies to ibuprofen or
aspirin, and (3) had no current knee or leg ailments.
subjects ranged from recreational exercisers to varsity
Ievel athletes, and were recruited for participation by
verbal announcements.
Rise.Time
Descriptive statistics for RT are shown in Tables
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1-, 2, and 3. RT was egual to the amount of time it
took to reach peak torque. A multivariate mixed model
ANOVA was used to determine whether any differences
existed amongi the treatment groups across the five
testing days. The three dependent variables used were
eccentric rise time at 60 deg/s (RTEcc6o), isokinetic
rise time at 1,2O deg/s (RTISOL2O), and isokinetic rise
time at 60 deg/s (RTrso6o). The Ievel of significance
for the tests of the interaction and main effects was
.05. The interaction F(24,276)=.984, group main effect
F(6,48)=1.1n, and day main effect F,(L2,2S]-)=1.S9 for
these RT variabres were not significant (see Tabre 4).
Peak Torque
The highest torgue outputr oE the pT, obtained
from the Biodex data, hras equar to the singre greatest
amount of force applied on a repetition. A
nurtivariate nixed moder ANovA was utilized to analyze
PT data. The three dependent variables used were
eccentric peak torgue at 60 deg/s (PTECC6O), isometric
peak torgue for direction 2 (PTIDIR2) (flexion), and
isokinetic peak torgue at L20 deg/s (PfrSOl-2O). The
means and standard deviations for each variable are
shown in Tables 5, 6, and 7. The level of significance
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Tab■e ■
Eccentric Rise Time 60 deq/S (RTECC60)
Group Mean* SD ??
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
Vitamin E
PLacebo
Ibuprofen
Vitamin E
Placebo
fbuprofen
Vitamin E
Placebo
Ibuprofen
■049
■003
■020
■■67
■023
■■43
■■92
■085
■043
■093
985
■067
■096
■223
■■74
432
227
■67
■79
22■
232
232
238
246
2■2
204
2■8
207
254
26■
?
?
?
??
?
?
??
?
??
?
??
?
?
??
?
?
* msec
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Table 2
fsokinetic Rise Time t-20 deq,/s (RTISO12O)
Day Group Mean:t SD ??
??
??
?
??
??
??
?
?
?
?
?
??
?
?
?
??
?
?
?
5
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
fbuprofen
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
242
223
260
227
247
259
225
233
271
226
238
247
224
234
222
39. L
32.9
23.8
53 .2
45.4
50.4
6r_. 5
24.5
55.2
49.8
44.2
43.9
3]-.7
3L.4
33.4
* msec
■
2
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Tab■e 3
1sokinetic Rise Time 60 deq/s(RTIS060)
Day Group Mean* SD ??
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
fbuprofen
Vitarnin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
354
346
366
333
346
337
355
3■6
370
322
33■
339
306
322
3■8
53.9
55。3
■00。0
87.8
97。6
74.2
■■5.4
60。5
9■.0
60。9
■6.5
59.6
4■.2
33.9
52.5
■■
■0
8
?
??
?
?
??
?
?
?
?
?
?
??
?
5
* msec
Tab■e 4
ANOVA Tab■ e for Rise Time
Sums
RTECCA
25■575
375246
3■7339
民f.::けares‐
39
WILKiS
LAMBDA
。765 ■.■4 .352
.823   ■.59  。093
.788   .984  。487
SOURCE
Days
Days x
Group
Error
RT60C df
475■2
277660
36972252
■9602
352042
276
⊇
?
?
Between Subiects
Groups    47555
Error   4430509
Within subiects
20850
99■20
55■7
■0849
■3■932
48
"Eccentric rise timebtsokinetic rise timeclsokinetic rise time
50 deg/s
L2o deg/s
60 deg/s
40
Tab■e 5
Eccentric Peak Toroue 60 deq/s (PTECC60)
Group Mean* SD ??
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
Vitarnin E
Placebo
Ibuprofen
Vitamin E
Placebo
fbuprofen
Vitamin E
Placebo
Ibuprofen
80.3
76。8
66.8
75.9
69.3
64.6
76。4
7■。6
60.5
75.■
73.■
64。■
80.3
87.0
70。4
■8.07
26.85
■2。24
37.64
22。63
■■.73
48.42
27。27
8.28
36.47
22.4■
7.77
40.6■
32。■6
■8.66
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
5 ■■■0
8
士 ft/■bS
3
Tab■e 6
Group Mean**
Vitamin E
Control
Ibuprofen
Vitamin EControl
fbuprofen
Vitamin E
Control
Ibuprofen
Vitamin E
Control
Ibuprofen
Vitamin E
Control
Ibuprofen
56.9
6■。5
54.0
43.9
47。8
49。4
43.0
43.9
47。3
45.8
5■.■
48.■
46。6
55.7
49。7
4.02
■0.54
■0。48
■2.38
■2。90
6.84
■3。35
■5.40
9。■3
■3.46
■2。77
5。70
■■.68
■2.5■
7.78
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
* values for sometr
士士 ft/■bs
raction of trings
`PTIDIR2)上
SD
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Table 7
Isokinetic Peak Torque l-20 deq/s (PTISO12O)
Day Group Mean士 SD ??
Vitamin E
Placebo
Ibuprofen
Vitanin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
75.3
8■.8
80.2
7■。5
89。6
78。4
73.5
87。5
82。3
77.3
87.8
82.7
77。2
90.9
80.■
■2。74
■0.88
■■。44
■■.96
■4.40
■2.87
7。97
■7.■8
9。64
■2.28
■5.84
■■.89
■0.60
■3。2■
9.96
?
??
??
?
??
?
■■
■0
8
■■
■0
7
?
?
?
5
士 ft/■bS
4
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for the tests of the interaction and main effects was
.05. As shown in Table 8, significant group x day
interaction F (24,267):1-.57 , and day main effect
F (L2 ,243 ) =8.31- were found. However, subseguent sirnple
group effects analyses for each day were non-
significant, indicating the three groups did not differ
from each other on any of the 5 days. Forlow-up tests
for time main effect hrere performed with three one-way
multivariate ANovA's to determine if oay 2 differed
from Days 3, 4, and 5. A significant difference was
found between Days 2 and 5 (F=.o22, p<.05) indicating
that on Day 5, the subjects' abirity to generate force
was significantry greater than that obtained on Day 2.
The group main effect was not significant F(6,48):.82g.
Tirne to Fatigue
Descriptive statistics for TTF are shown in Tabre
9- The means and standard deviations for each group
across the 5 days are indicative of the amount of time
it took each subject's torgue reading to be reduced by
one halfr 
€rS measured by a combination of isokinetic
reg flexion and extensions. A mixed moder ANoVA was
used to determine if the groups differed over the
testing period. The revel of significance for the
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Tab■e 8
ANOVA Tab■e for Peak Torque
Sums of SguaresqB]吾
:こb PTISO■20Cdf
WILK:S
LAMBDA    ェ p
48    .82■   。829  .553
SOURCE    PTIDIR2a
Between Subiects
Groups 43■
Error     ■37■6
Within subiects
■983
80224
2460
■4998
Days
Days x
Group
Error
225■
489
2425
■963
874
24683
352
347
2899
249
267
.403  8。3■   .00o
.682  ■.57   。047
sometricbEccentric
cfsokinetic torguetorgue
60 deg/s
■20 deg/s
peak
peak
r peak
orquedirection 2 (hamstrngslflexors)
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Tab■e 9
Time To Fatique
Day Group Mean* SD ??
Vitarnin E
Placebo
fbuprofen
Vitarnin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
Vitanin E
Placebo
Ibuprofen
Vitanin E
Placebo
Ibuprofen
40。0
45.2
44.3
44.0
4■。6
45.2
45。3
40.6
47.5
45.2
45.■
44。2
44.4
47.9
48。7
9.27
8。0■
7。2■
7.75
9.■5
6.25
7.■3
9。3■
6.■5
7.06
9。■2
7.37
7。07
■0。03
7.75
??
?
■0
■0
8
■0
■0
8
?
?
?
4
?
?
?
?5
* seconds
■
45
tests of the interaction and main effects was .05. The
group x day interaction was significant F(9,84):2.23,
indicating that the trend of the three groupsf mean TTF
scores differed over the 5 days (see Tabre 10). The
day main effect was also significant F(4,84)=3.21. The
group main effect was not significant F(2,2L):.L9.
simple effects for groups at days showed significant
differences between the groups only at Day 1 (F:2.31_,
p<.05). The groupst scores were not significantly
different on Days 2, 3, 4, and 5. Forlow-up Bonferroni
pairwise contrasts showed no significant differences
between the groups at Day L (L vs. 2 L=2.t4i 2 vs. 3
t=.575; l- vs. 3 t=1.45r p>.05). fn addition, the
Bonferroni contrasts for day main effect showed no
significant differences between mean scores on Days 2
and 3 (t=.8L1, p).05), 2 and 4 (t=.956, p>.05), or 2
and 5 (t:2.4O, p>.05), indicating that the subjectsr
scores did not differ between the specific days of
interest.
Perception of performance
rn Table LL, the means and standard deviations for
each grouprs pp for 4 testing days are shown. A mixed
model ANOVA was used to determine if the groups
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Tab■e ■o
ANOVA Tab■e fOr Time To Fatigue
Source SS df MS F p
Between Subjects
Group 83 .8 6 2 41.93 
. 19 .831
Error 4726.9t 2L 225.09
Within Subjects
Days 3l-8 . 70 4 79 .68 3 .27 . 015
Days x 434.82 8 54.35 2.23 .033Group
Error 2O49.O5 84 24.39
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TabLe 1L
Perception of Performance
Day Group Mean* SD ??
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
fbuprofen
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
fbuprofen
9.33
9. l-0
8.L2
9.25
8.70
8.L2
L2.3
L3.2
10. 6
L5.0
L5.7
L2.O
L.97
L.29
1.7 3
3.39
3.37
2.75
3 .65
3.39
3.25
3. 63
2 .58
2.93
?
?
?
?
?
?
?
?
?
?
?
?
?
???
????
*sum of scores bas on scale of L-7
2
5
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differed across the 4 days. The level of significance
for the interaction and rnain effects was .O5. The
group x day interaction was not significant F(6,50)=.75
while the day main effect was significant F(3,81-):31.40
(See Table L2). The group main effect was not
significant, however, it nearly attained significance
F(2,271=2.7t. The day main effect was followed up with
Bonferroni pairwise contrasts and showed a significant
difference between mean scores on Days 2 (M=8.93) and 4
(M=L2.L7) (E:4.78, p<.05), and Days 2 (M:8.93) and 5
(l{:14 .47 ) (t=8 . L8 , p< . 05 ) . However, Do dif ference was
found between Days 2 and 3 (t=.245, p>.05) . These
results indicate that subjects perceived they could
produce greater force on the fourth and fifth days,
compared to the first day following soreness induction.
Soreness
The means and standard deviations for RS in the
exercised (dominant) legs for each group over the 5
days are displayed in Table L3. A mixed model ANOVA
was used to determine if any differences existed in RS
among the groups and/or across the days. The 1evel of
significance for the tests of the interaction and main
effects was .05. The group x day interaction
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Tab■e ■2
ANOVA Tab■e for perception of perfoェ‖tance
Source SS df MS
Between Subiects
p??
Group
Error
Within subiects
Days
Days x
Group
Error
8■。92
404。72
632.74
30.■2
544.08
2。69士
6
72。7士
40.96
■4.99
2■0.9■
5。02
6。72
2.73
3■。40
.75
。083
。000
.6■3
????
?
* Huynh-Feldt adjusted
5■
Tab■e ■3
Ratinqs of soreness
Day Group Mean* SD ??
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
Vitamin E
Placebo
Ibuprofen
■。82
2。22
■.98
3。52
2。98
3。05
3.64
3。88
3.■5
2。66
2。32
2.20
■。28
■.■4
■.52
■。02
■。06
■.35
.80■
■.0■0
.7■5
.974
。839
.52■
.900
■.080
.849
.880
。985
。555
?
?
?
??
?
???
??
?
??
?
?
??
*mean scores based on scale of 0-6
5
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F(8r 44):1.2U, and the group main effect F(2,25):.23
were not significant, while a significant day main
effect F(4,22):39.44 was found (See Table 14).
Bonferroni contrasts for day main effect showed no
significant differences between Days 2 and 3 (t:L.94,
p>.05), but did show significant differences between
mean scores on Days 2 (M:3.19) and 4 (M:2.4J-) (t:3.9,
p<.05), and Days 2 (M=3.19) and 5 (M:1.30) (t=9.3,
p<.05). These results indicate that between Days 2 and
3, the subjectsr soreness was reaching its peak, so a
significant difference lras not found. However, by Days
4 and 5, sensations of soreness were on the decline
leading to the significant differences between the
early and later days.
Tab■e ■4
ANOVA Tab■e for Ratinos of Soreness
Source SS
Between Subjects
Group .93
Error 5L.46
Within Subiects
Days
Days x
Group
Error
89.93
5.70
56.93
2
25
3.65
8
94。0
MS
.47
2.06
22。46
。7■
。57
*Huynh-Feldt adjusted
Chapter 5
DTSCUSSION OF RESULTS
The findings from this study demonstrate that the
use of IB or E did not provide relief from DOMS, nor
did they have a significant effect on the decrine in
rnuscular performance that accompanies DoMS. However,
individual perception of performance ratings
(regardless of group) did increase as days passed and
soreness subsided. A discussion of these results are
presented in this chapter under the following
subtopics: (a) muscular performance variables, (b)
perception of performance and soreness, (c)
irnplications of findings, and (d) sunmary.
Muscular performance Variables
In the present study, muscular performance as
represented by RT, PT, and TTF were the variables
serected from the Biodex measurements for analysis. RT
(i.e., the time to reach peak torgue) did not differ
between the three groups over the course of testing.
Peak soreness occurred for aII groups at Day 3 (49
hours postexercise) but did not correspond with a
significant change in RT. The fact that RT was not
notably altered may be due to the time frame in which
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it was analyzed. According to Clarkson and Tremblay
(L988), the greatest force reduction occurs immediately
following eccentric exercise, which is before the onset
of DOMS. The present study analyzed RT at 24-hour
intervals postexercise, which may have missed the
greatest reduction in RT.
According to Snith (L991), inability of a sore
muscle to generate force occurs from acute j-nflammation
following eccentric or negative contractions. Although
not clearly understood, the loss of function is thought
to be due to the presence of a mechanical barrier from
swelling and/or due to a reflex inhibition of the
muscles experiencing pain. These decrements in
performance have been seen imrnediately postexercise and
can return to baseline by 24 h or take up to L4 days
later to normalize (Smith, L991,) .
Analyses of PT (i.e., force) indicated the groups
were performing similarly after Day 1. pT decreased at
24 h postexercise for all groups and had increased by
the fourth day after inducing soreness.
In the present study, aII three groupst pT did
decline at 24 h postexercise (Day 2) and began to
improve by 48 h (Day 3). fnterestingly, this
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improvement occurred at the same time as pp was 1owest
and soreness sensations at their peak. These findings
may indicate that PP was not an accurate reflection of
performance, but rather an accurate reflection of
soreness sensati-ons.
Following a stepping exerciser'Newham et al.
(l-983) found that ultrastructural changes were 1imited
to only the muscles worked eccentrically and not to
those worked concentrically or isometrically. It may
be that soreness reported in the present study was
rimited to sensations in eccentricarry damaged muscre
fibers, which should have been enough to produce a
marked decrease in strength performance variables
(i.e., RT and PT). AIso, it was assumed that maximal
effort was being exerted by each subject for a1l
testing purposes. During the soreness induction
protocol on Day L, subjects may have been unfarniliar
and possibly apprehensive when trying to give a
rrmaximaltt effort and conseguently, less damage and
soreness occurred.
A plausible explanation for this reported lack of
significance may involve the combination of
contractions used in the soreness protocol. There may
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not have been a sufficient amount of adequatety intense
eccentric contractions performed to assure enough
damage and swelling to elicit extreme soreness. The
sguat exercise performed at 804 of L RM (for five sets
of LO repetitions plus an eccentric set) utilized both
concentric and eccentric contractions of the guadriceps
and hamstring muscle groups, while the Biodex protocol
used a combination of concentric, eccentric, and
isometric contractions. According to the soreness
scale that was administered, the maximal mean score
reached was only 3.88 out of a possible G points at
peak soreness. This number corresponded to rmore than
slight painrr or ttpainfulrt which may not have been
enough to significantry inhibit muscurar performance.
The third muscle function test used to assess the
impact of DoMS on performance was TTF. rn the present
study, all three groupst scores were similar, except
prior to DOMS induction when the E group displayed
significantly longer TTF than the IB or p groups.
However, during the 4 days following soreness
induction, arr groups demonstrated a simirar trend in
TTF performance in that there was no significant change
across the 4 days for any of the groups. In their
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investigation, Davies and White (L981-) found no
significant differences in relative strength decrement
during a 2-minute muscle fatigue test 20 h after
eccentric exercise was performed. The authors
suggested the possibility that the relative endurance
capabilities of the muscle (i.e., slotr twitch fibers)
were not affected by DOMS. This may have been the case
in the present study.
Perception of Performance and Soreness
An individualrs perception of his/her ability to
perform when soreness is present is critical. If the
damage is severe enough to hinder muscular performance,
an individual should be able to recognize this through
sensations of soreness and therefore, be able to
protect themselves against further injury. In the
present study, subjects were asked to rank themselves
prior to testing each day, compared to their
performance on each previous day. Perception scales
were completed on each day following the induction of
soreness. It was shown that PP changed over the 5-day
testing period. Significant changes were seen between
24 and 72 h and between 24 and 96 h postexercise, which
coincided with the rise (24 h post) and then decline
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(72 h post) in sensations of soreness. At 24 h
postexercise, PP was Iow, but by 72 h when soreness was
subsiding, PP was increasing. These changes in pp and
RS were reported while performance scores were
essentially unaffected by DOMS occurrance. Although
there was no significant diffe,rence between the three
groups, it appeared as though the fB group had a
consistently lower perception of their daity
performance than the E or P groups (p=.Ogg). Whi1e
possibly reducing inflammation during the healing
process, IB seemed to also lessen subjectsr perception
of performance ability. The mechanisrn that accounted
for this perception is unknown, but this phenomenon may
serve to rrprotect'r damaged muscre fibers by preventing
overexertion and further injury.
Soreness perception scales were completed at the
beginning of all five testing sessions. Once again,
results indicated that the subjectsr soreness ratings
were changing over time. Similar to pp, RS was
significantly changing from 24 to 72 and 96 h
postexercise. By 24 h postexercise, all three grouprs
soreness ratings were beginning to peak, but by 72 to
95 h, soreness was on the decline. This observation
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may be evidence that there is a strong relationship
between RS and PP regardless of treatment used. The
congruency of these two-measures points to an accuracy
of human perception that may serve to protect the
organism against further exercise-induced damage. In
this regard, it is fortunate that IB and E
administration do not confound the sensitivity of that
perception.
Hurnan perceptions of soreness continue to be a
confusing problem today. The variability among
individuals makes it even more difficutt to point to
any one mechanism leading to DOMS. Byrnes and Clarkson
(l-986) and Clarkson et aI. (1985) explain their large
intersubject variability in soreness perception as due
to different nervous system pathways. They claim the
reason for such fluctuation is due to the various
receptor types (for the Reticular Activating System and
cortex) and pain regulating abilities. In other
studies, it has been suggested that exercise increases
the release of endorphins which could potentially
provide an analgesic effect, minimizing the sensation
of DOMS during the exercise period. Another mechanisrn
for alleviation of soreness may result fron the subject
5l-
focusing attention toward the activity and away from
the pain at the cortical IeveI in the brain (Armstrong,
r-e84 ) .
Jones, Newham, Round, & Tolfree (1996) noted
consj-derable variability among subjects in the severity
of soreness responses to damaged muscre fibers. They
attributed this resurt to differences in training and
activity IeveIs, which have been found to protect
muscre against such damage. However, the researchers
hypothesized that this could not be the ful1
expranation as no obvious correration has been seen
between susceptibility to damage and factors such as
d9e, sex or general activity leve1.
Implications of Findincrs
Because there were no obvious differences among
the three groups in muscular performance, pp, or RS,
the effectiveness of both rB and E use in prevention
and/or treatment of DOMS must be guestioned.
Studies on E are inconclusive regarding itrs
antioxidant abilities during physical exercise.
tunelink et aI. (L991) found that after 5 weeks on an E
deficient diet, rats were more susceptible to exercise-
induced muscle damage following a 2 h endurance
treadrnill run. These results indicated a possible
not definite, increase in lipid peroxidation.
Similarly, Quintanilha (L984) conducted a 9-week
experiment where an E deficient diet was fed to both
sedentary and endurance trained rats. The author found
that endurance trained rats exhibited less red blood
cell hemolysisr, which may have indicated a lowered rate
of lipid peroxidation.
In a study by Jenkins (L983), it was found that
unaccustomed, acute bouts of exercise increased lipid
peroxidation in untrained rats. The author
hypothesized that endurance training wourd reduce ripid
peroxi-dation by decreasing circurating catechoramines.
The present study utilized muscular contractions
to produce muscle fiber damage and induce soreness.
Several reasons for lack of differences among the
groups following L9 days of E use may be: (1) subjects
had various aerobic fitness revels, (2) the exercises
used were anaerobic in nature and did not produce a
substantiar amount of oxygen-mediated free radicars,
and (3) the dosage and supptementation time may not
have been enough to produce a 'protectiverr effect on
ceII membranes.
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In the present study IB, like E, lacked any
noteworthy effect on muscular performance and soreness.
Donnelly et aI. (1988) administered Diclofenac, an
anti-inflammatory drug, to untrained males prior to and
72 h following a 4S-minute eccentric treadmill run.
They found that the drug had no influence on muscle
damage, but may have slightly reduced soreness
perceptions in certain individuals. Donnelly et al.
also noted the only evidence for the effectiveness of
anti-inflammatory drugs for DOMS in humans, was one in
which aspirin reduced soreness and prevented changes in
prostaglandin E and F2 alpha levels observed in a
control group (Bansil, Wilson, & Stone, L9g5). In
L974, Muckre compared rB and aspirin in terms of their
analgesic effects on soft tissue injuries and
effectiveness for return to soccer playing. He
that the L200 mg dose of IB (daily for 5 days)
decreased the duration and severity of pain-and
players to return earlier to training and match
than did aspirin. Muck1e also stressed that to
IBrs effectiveness, the drug would have to be
administered within a short period after injury,
the local biochemical changes are beginning.
found
helped
play
utilize
when
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In this study, a l-2OO mg dose of IB was taken 2
days prior to and throughout the 5 days of testing.
Although the dose given was similar to that of Mucklets
study, the present study dealt with muscle soreness,
not soft tissue injuries (i.e., groin strains, muscle
hematomas, subcutaneous bruising). The inflammation
accompanying these types of soft tissue injuries might
be much more pronounced than the muscle fiber damage
induced, therefore, a significant effect of the
treatment was not seen in this study.
Another important consideration in the
identification of DoMS and its response to treatment is
the design of a study. Janssen et aI. (1983) examined
the effect of an anti-inflammatory drug on muscle
soreness and serum CK changes. They had subjects
perform the same exercise protocol on two separate days
using a crossover design, and although they concluded
the drug had no significant effects, the repeated bout
of exercise may have masked the actual effect. In the
present study, the same exercises were repeated over
five consecutive days. Because the repeated bout
effect is so large, dDy treatment effects from fB would
have to have been of great magnitude in order to be
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detected.
Horarever, ds mentioned previously, the fB group did
have a consistently lower PP compared to the other two
groups. This observation may warrant further research
to look at IBrs potential to have a ttprotectivert effect
in humans during exercise in the presence of DOMS.
Summary
It is well known that unaccustomed activity
produces DOMS, the sensation of pain and stiffness in
the muscles that occurs anlnrrhere from 24 to 48 h
postexercise and can last up to 5 days (Armstrong,
L984). IB, with itts anti-inflammatory properties, mdy
be able to reduce the swelling and/or inflammation
which is thought to be a mechanism following muscle
fiber damage (Smith, 1991). The anti-oxidant
properties of E may be able to maintain the integrity
of the ceIl by preventing the propagation of lipid
peroxidation (Amelink et aI., 199L). In this study, it
was proposed that each wouLd have an influence on
preventing muscle fiber damage, attenuating the DOMS
sensation, and possibly improving performance.
The results of the present study indicate that
three groups had similar muscular performances over
?
? ???
?
?
?
???
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course of testing regardless of the treatment used.
Following soreness induction, pr did decrine by 24 h,
but there was no change in RT and TTF measures. A
paraller between pp and RS was noted, however, and must
be viewed as an important initial finding. More
research should be conducted regarding rBrs effect on
perception and soreness so as to understand more fuI1y
its potentiar to combat overuse injuries in athletes
experiencing DOMS.
→
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Chapter 5
stMMARY, CONCLUSTONS, AND RECOMMENDATIONS
Summarv
This study was designed to determine whether or
not the use of rB or E reduces the perception of
soreness or affects the decrine in muscular performance
that usualry accompanies DOMS. A secondary purpose was
to determine each grouprs abrility to perceive their
performance following the onset of DOMS.
E and p were taken 2 weeks prior to and throughout
testing, while IB was taken 2 days prior to and
throughout the 5-day testing period. Baseline
measurernents on the Biodex consisted of maximal
isometric, eccentric, and concentric contractions of
the guadriceps and hamstring muscres. rmmediatery
after baserine testing, subjects performed a series of
near maximal sguats to induce soreness in the upper
Iegs. RS and pp scales were completed daiIy.
Murtivariate mixed models were used to compare the rB
vs. E vs. P groups on selected RT, pT, and TTF
measurements over the 5 days. Rs and pp measures were
anaryzed with.a mixed moder ANovA. overarr results
indicated that RT did not change between the groups
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over the testing period. Analysis for pr revealed that
rB, E, and P groups all performed similarly throughout
testing, and that pr declined initially following
soreness, but then recovered between 24 and 96 h
postexercise. Analysis of TTF indicated that the
groups performed differently at baseline testing on Day
t, but then performed i-n a simirar fashion for the
remainder of the testing period. The IB group's pp
tended to be consistently rower than E or p, however,
this trend did not reach significance. Arr subjectsl
PP tended to increase from 24 to 72 and 96 h
postexercise, but not from 24 to 4g h postexercise.
Anarysis of RS showed no differences between rB, E, and
P groups over the testing period, and that arl subjects
peaked in soreness by 48 h postexercise and began to
recover thereafter. pp forlowed a similar trend and
therefore, tended to reflect RS rather than
performance.
Conclusions
The results of this study Ied to the folrowing
conclusions regarding the effect of rB and E on DOMS
and performance:
l-- Muscular performance was not significantly
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artered by the use of rB or E in the presence of DOMS.
2. RS was not significantry different between rB,
E, and P groups. However, soreness sensations peaked
for arl groups by 48 h postexercise and began to recede
thereafter.
3. PP did not significantly differ among the
three groups, although the rB group was consistently
Iower than E or p groups for the 5 days of testing.
Recommendations
The forlowing reconmendations for further study
were made after the compretion of this investigation:
1. Future studies should use a
with only eccentric contractionsr 
€ls
contractions tend to elicit the most
responses, and drop in performance.
2. Future studies shourd use variabre doses and
supprementation times to determine which treatment may
be beneficial.
3. A similar study should include a practice
session far enough in advance that subjects gain
familiarity with the apparatus and testing protocor so
as to avoid a learning effect and possibre interference
in the soreness protocol.
soreness protocol
these types of
damage, soreness
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4- Future studies shoul-d examine more crosely the
rerationship between rB and pp and the possibility of a
protective effect in humans.
5. Future studies should pre-match subjects for
activity levels before placing into groups.
5. Pp and RS should be scaled based on
percenta€Jes rather than the Likert-type scale for more
accurate analyses.
Appendix A
ITHACA COLLEGE FITNESS PROGRAM
MEDICAL HISTORY/HEALTH HABIT QUESTIONNAIRE
Age         Birthdate
Phone
Phone
Name
School Address
Home Address
Present Physician
FAMTLY HTSTORY 
- Check if any blood
etc. ) had?Heart Disease ( ) Stroke (High Blood Pressure ( ) High
Other conditions/comments :
MEDICAL/HEALTH HttSTORY ― Check if you have ever had?
Heart Disease/Stroke ( )High Blood Pressure
Heart MurmurSkipped, rapid beats
relatives (parents, siblings,
) Diabetes ( )Cholesterol ( )
Lung Disease
Diabetes
High Cholesterol
Epilepsy
Injuries to back,
kneesr or ankles
stomach ulcer
you are pregnant, please
or irregu■ar rhythms   ( )
Rheumatic fever
Cancer
Pregnant
()
()
()
(   )
(   )
Other conditions/comments :
** If you have reason to believe
state symptoms here
PRESENT SYMPTOMS 
- Have you recentty had?
Chest pain ( )Shortness of breath ( )Lightheadedness ( )Heart palpitations ( )Loss of consciousness ( )
Other conditions/cOmments:
LIST ALL MEDICATIONS PRESENTLY TAKING:
工■■ness′ surgery′ Orhospita■izatiOn   ( )
3:Il:′l::cittellllgl l
Allergies         ( )
A■■ergic tO aspir■n? Y/N
Advil (ibuplttl:1,:?Y)(N
7■
()
()
()
()
()
()
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HEALTH HABITS
■。 SMOKING HISTORY
Do yOu smoke? Yes ( ) No (
How much did(do)yOu smoke
How ■ong have(had)you been
lf quit′ when?
Do you have discomfort,
exercise? Yes ( ) No (ff Yes, what type(s) of
3. NUTRTTIONAL BEHAVIOR
Do you consider yourselfIf so, how long have you
If Yes′ what?
4. STRESS
) Quit (a day?
smoking?
2。 EXERCISE HABITS
Are yOu present■y active? Yes ( )
What type of activity?
No ( )
How hard? Light ( ) ltoaerHow often? ■-2d/wk ( )2-4d/wk ( )5+d/wk ( )
Did your past exercise habits differ from whatdoing now? Yes ( ) No ( )What kind of exercise did you do in thepast?_
ttow tr
How often? t-2d/wk ( ) 2-4d/wk ( ) S+d/wk ( )
Is your present occupation- Sedentary ( ) Active ( )Heavywork ( ) Explain:
youare
shortness of breathr oF pain with
)
exercise?
overweight? Yes() No()been overweight?
How many meals do you eat on a tlpical day?
How often do you eat meals outside of the nomea-
Do you presently consume alcohol? yes ( ) No ( )Number of dr■nks/wk
Do you consider your day stressful? yes ( ) No ( )What is the nature of your stress?
How many hours (average) do you sleEp at-nfgfrt?Is your sleep sound? Yes ( ) No ( )
ADDITIONAL PERTINENT ttNFORMATION8
SIGNATURE DATE
工 .
Appendix B
INFORI{ED CONSENT FORU
Purpose of the studyThis study has been designed to investigate thepossibility that ibuprofen and/or vitarnin E will decreasepain and improve performance in a muscle grouP
experiencing muscle soreness.
fI. Benefits of the studv
The results from this study will help sports rnedicine
related professionals to better understand the effects of
ibuprofen and vitamin E when they are administered toindividuals before and during episodes of muscle
soreness. This will provide insight into how muscle
soreness may be treated for athletic injuries or
unaccustomed exercise (e.9., stair climbing). Another
benefit would be the possibility that performance rnay be
affected by the treatnents which could be very important
infornation for athletes as well as regular exercisers.
III. Subject participation
Anount of tine needed: The amount of time comnitment
involved wilI be approximately t hour the first day, and
approxinately 30 minutes for each of the subsequent days. The
total amount of sessions are on 5 consecutive days.Tasks and procedures: Prior to adninistration of
rnedications, aII subjects will be asked to give a urine sample.
Then, two days preceding the initial testing, you will be asked to
take (2) 200 mg doses of ibuprofen three times a day, every four to
six hours, with food or milk. or, 2 weeks prior to initial
testing, you will be asked to take (2) 400 IU gelcaps of vitarnin E
with food or milk. You will continue to follow this procedure
until the final day of testing, which will be a total of 7 days (if
ibuprofen) or 19 days (if vitanin E). On the first day and each
subsequent day, you will be asked to complete 2 questionnairesr'a
soreness scale, and a perception of performance scale. These two
forms will aid in the interpretation of the data collected frorn the
exercise tests. You will then be asked to perform several bouts of
exercises requiring rnaximum effort invol-ving the upper leg muscles.
These tests will be performed on the Biodex, a computerized device
used to interpret and assess po$rer and strength of muscles.
Following that, you wiII be asked to exert maximal efforts on a
Universal squat machine. After the first day of exercise testing,
you will experience some muscle soreness and discomfort. This is
to be expected and should subside within a few days during testing.
You will be asked to perform the same initial exercises on the
Biodex for 5 consecutive days, and to continue to take theibuprofen or vitamin E until the final day of testing. In
addition, blood samples will also be taken following exercise on
several occasions. This wiIl aid in the analysis of the actions of
ITHACA COTLEGE LIERARY
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the supplements given. All testing wilt take place in the Exercise
Physiology lab in HilI Center (Room #+e7.
AIso included is an exerpt from the United States
Pharmacopeial Convention regarding various pieces of information onibuprofen. AIl subjects rnust read this exerpt before the start oftesting.
IV. Risks associated with participation:
This study will cause you to experience muscLe soreness.This soreness should only last a few days, and should not preventyou from carrying on your normal daily activities.
Maxirnum effort exercises cannot be performed without some
minor risk of injury. A11 precautions wiII be taken to minimizethis risk and assure your safety. The Biodex and the Universal
squat machine are very safe and effective exercise devices and the
researchers are well trained on their use. Exercise testing wiIIbe supervised at all times by at least one of the researcheis.
rbuprofen is an over the counter drug that has been
approved by the FDA and is considered safe for general consumption.fbuprofen should not be taken if you have a known allergic reactionto aspirin or non-aspirin pain reriever, such as tyrenorr oribuprofen itself. Some of the possible side effects of iUuprofenincrude gastrointestinal (stomach) probrems, dizziness, rash,
weight gain, and retention of fluids. These side effects are not,
common among the majority of peopre and are highly unlikely to
occur with the smalr dosage and short duration oi this stuay.
rbuprofen shourd be taken with mears or a grass of milkVitamin E is a fat soluble substance that is found in theceII membranes within our bodies. ft is known as an antioxidantbecause of its ability to protect the membrane from darnagingeffects of free radicals that can be produced with exercLse]To:icity is very rare with this vitamin and has only been cited in
animals after administration of extrernely high dosages. Adverseeffects that. may occur include nausea and gastrointestinal(stonach) problems.In summary, this study involves only safe experimentalprotocols that are common in exercise physiology research. rf youare arrergic to aspirin, Tylenol (acetaminophLn), or ibuprofln,have had a previous ulcer, are pregnant, currentry smokecigarettes, or have an injury contraindiclting'exercise, -yo. willbe excruded from the study. Hopefulry this study wiir-provideinformation of great interLst to you ai weII as slports medicineexperts, coaches, athletes, and arr those that exercise.
V. Need more information?ff you would like more information or would like to knowof the results of the study, please feel free to contact
susan Kofod at 2s6-2346. Dr. G.A. sforzo, Department ofExercise sport and Science, wiII also be'ablL to answeiyou! questions. Dr. sforzo may be contacted in hisoffice Room 41, HiII Center at 277-3359.
vr.
VII.
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Withdrawel from the studv:Participation in this study is voluntary, and you arefree to withdraw at any time. If you have any questions
about the study, risks, oE procedures, we will be happy
to answer them before or after you agree to participate.
If you choose to withdraw from the study, You will not
suffer any penaltY of anY kind.
Will the data be maintained in confidence?AIl of the pa::ticipants in this study will be given a
number code that will be used whenever related data is
analyzed or presented. All data, questionnaire anshlers,
and results will be kept completely confidential.
Thank you for your time in considering this study and
especially for your participation.
I have read the above information and understand its
contents. I have also read the exerpt on ibuprofen and
have had the opportunity to ask questions if I need to.
Signature Date
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NAME:
Appendix c
24-Hour History
DATE:
SLEEP DID YOU GET LAST NIGHT? (P■ease circ■e one)
2    3    4    5    6    7    8    9    ■0 (hOurs)
SLEEP DO YOU NORMALLY GET? (P■ ease circle one)
2    3    4    5    6    7    8    9    ■0 (hOurs)
HAS IT BEEN SINCE YOUR LAST MEAL OR SNACK?
3  4  5  6  7  8  9  ■0 ■■  ■2  ■3 ■4 (hourS)
ITEM(S)EATEN BELOW:
TIME8
HOW MUCH
■
HOW MUCH
■
HOW LONG
■  2
LIST THE
WHEN DID YOU LAST:
Have a cup of coffee or tea
Smoke a cigarette, cigar, or pipe
Take drugs (including aspirin)
Drink alcohol
Give blood
Have an illness
Suffer from respiratory problems .
WHAT SORT OF PHYSICAL EXERCISE DID YOUP RFORM YESTERDAY?
WHAT SORT OF PHYSICAL EXERCISE DID YOU PERFORM TODAY?
DESCRIBE YOUR GENERAL FEELINCS BY
Exce■■ent
CHECKING ONE OF THE FOLLOWttNG8
Bad
Very′ very badVery bad
Terr■b e
l LAST 24 HOURS?
Very, very good
Very good
Neither good nor bad
HAVE YOU HAD ANY STOMACH CRAMP /PAINS IN THE
Yes          No
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Appendix D
Perception of Performance Sca1e
Subject
Cornplete the following statements with the answer that best suits
the way you feel today. Please take your time and read the
statements carefully.
Exercised Leg
Today, in comparison to my previous
isometric strength performance wiII
123
test(s), I
be: (please
5
feel that my
circle one)
much somewhat slightly
weaker weaker weaker
the same slightlybetter somewhat muchbetter better
Today,
dynarnic
2
in comparison to my previous
strength performance will be:test(s), I feel that my(please circle one)
much
weaker
somewhat
weaker
slightly the same slightly
weaker better somewhat muchbetter better
Today, in comparison
range of motion will
to my previous test(s), I feel that mybe: (please circle one)
much somewhat slightly
weaker weaker weaker
the same slightly
better sornewhat muchbetter better
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Subject Number:
Unexercised Leq
Today, in comparison to my previous
isometric strength performance will teSt(S)′ Ibe3 (p■eaSe
5
feel that ny
circle one)
much somewhat
weaker weaker
slightty the
weaker
slightly somewhat muchbetter better better
Today, in comparison to ny previous test(s), I feel
dynamic strength performance will be: (please circle
3          4          5           6
that my
one)
7
much somewhat slightly
weaker weaker weaker the sane slightly somewhatbetter better muchbetter
Today, in comparison
range of motion will to my previous test(s), I feel that mybe: (please circle one)
much somewhat slightly
weaker weaker weaker
the same slightly somewhat muchbetter better better
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Initia■s
Date
EXERCISED LEC
Pain: None
UNEXERC=SED LEG
Pa■n3 None
Appendix E
80RENESS RAT工NC ScALE
Vague SlightSlight + painful painful +
Vague Slight    slight +  Painful   Painfu■ +
None 
- Mild, bearly perceptible symptoms of pain
Vague DuII ache upon palpation
sIight Persistent discomfort, but does not interfere withmovement
slight + 
- sorness which hampers comprex movement
Painful constant pain and stiffness which interferes with mostdaily tasks
Painfur + continuar pain without movement
④
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